{ "custom_id": "syn24875850",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"DNA methylation signatures in peripheral leukocytes of patients with Schwannomatosis or sporadic schwannoma\",\n    \"creator\": \"Dr. Gelareh Zadeh\",\n    \"contributor\": [\n      \"Sheila Mansouri\",\n      \"Robert Allaway\",\n      \"University Health Network of Toronto\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"DNA methylation\",\n      \"leukocytes\",\n      \"peripheral blood\",\n      \"schwannomatosis\",\n      \"sporadic schwannoma\",\n      \"immune cells\",\n      \"immune cell deconvolution\",\n      \"methylation array\",\n      \"biomarker\",\n      \"IDAT\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn24875850\",\n    \"diseaseFocus\": [\n      \"Schwannomatosis-NOS\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw DNA methylation data (IDAT files) from peripheral blood leukocytes of 54 individuals, including patients diagnosed with schwannomatosis or sporadic schwannoma. Generated using methylation arrays for immune cell composition analysis.\",\n    \"alternateName\": \"Schwannomatosis Blood Methylation Signatures\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 54,\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"methylation array\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 54,\n    \"subject\": [\n      \"DNA methylation\",\n      \"Leukocytes\",\n      \"Schwannoma\",\n      \"Biomarkers\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 3202,
            "endIndex": 3346,
            "uri": "https://www.ctf.org.au/page/112/schwannomatosis",
            "license": ""
          },
          {
            "startIndex": 3233,
            "endIndex": 3373,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5302,
    "candidatesTokenCount": 457,
    "totalTokenCount": 5759,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5302
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn21355225",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Antisense Oligonucleotide (AON) Treatment Effects on NF2 Patient Fibroblasts\",\n    \"creator\": \"Elisabeth Castellanos\",\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"NF2 AON Fibroblast Study Data\",\n    \"contributor\": [\n      \"Germans Trias I Pujol Research Institute (IGTP)\",\n      \"Hospital Universitari Germans Trias i Pujol (HUGTP)\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"geneExpression\",\n      \"proteomics\",\n      \"image\",\n      \"cellularPhysiology\"\n    ],\n    \"dataUseModifiers\": [\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Results from treating primary fibroblasts from NF2 patients with antisense oligonucleotides (AONs/PMOs). Includes functional analysis data (RT-PCR, Western blot, immunofluorescence, proliferation) to evaluate AON effects on NF2 mutations and Merlin protein function.\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 15,\n    \"keywords\": [\n      \"Neurofibromatosis Type 2\",\n      \"NF2\",\n      \"NF2-related schwannomatosis\",\n      \"Antisense Oligonucleotides\",\n      \"AON\",\n      \"PMO\",\n      \"Fibroblasts\",\n      \"Merlin\",\n      \"Splicing\",\n      \"Exon Skipping\",\n      \"Personalized Medicine\",\n      \"In Vitro\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"polymerase chain reaction\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn21355225\",\n    \"subject\": [\n      \"Neurofibromatosis Type 2\",\n      \"Antisense Oligonucleotides (Pharmacology)\",\n      \"Fibroblasts\",\n      \"Gene Expression Regulation\",\n      \"Molecular Therapy\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 1191,
            "endIndex": 1340,
            "uri": "http://globalauthorid.com/WebPortal/ArticleView?wd=1CDD87D871F5F69E84F43869D36E69434F487AE8B34E09E2C91AE51BDA16E00A",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6193,
    "candidatesTokenCount": 533,
    "totalTokenCount": 6726,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6193
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn4984604",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Robert Allaway\",\n    \"dataType\": [\n      \"clinical\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Immunohistochemistry data characterizing cutaneous neurofibromas from NF1 patients in the CTF Biobank pilot project.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\",\n      \"Molecular Characterization\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"immunohistochemistry\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Immunohistochemistry\"\n    ],\n    \"title\": \"Immunohistochemistry\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Thomas Yu\",\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Raw sequencing data (FASTQ format) intended for processing by NF-OSI, related to the CTF Biobank cNF pilot project. Date likely refers to processing batch initiation.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"Raw Data\",\n      \"Sequencing\",\n      \"FASTQ\",\n      \"NFOSI\",\n      \"CTF Biobank\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Genomics\",\n      \"RNA Sequencing\",\n      \"Whole Genome Sequencing\",\n      \"Raw data\"\n    ],\n    \"title\": \"NFOSI Raw Data for Processing (2023-07-21)\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Sara Gosline\",\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Proteomics data (MudPIT) characterizing cutaneous neurofibromas and matched samples from 11 NF1 patients in the CTF Biobank pilot project.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"keywords\": [\n      \"Proteomics\",\n      \"MudPIT\",\n      \"Mass Spectrometry\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\",\n      \"Molecular Characterization\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"MudPIT\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 40,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Proteomics\",\n      \"Mass Spectrometry\"\n    ],\n    \"title\": \"Proteomics\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Thomas Yu, Sara Gosline, Robert Allaway\",\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Processed RNA sequencing data (including alignments and gene expression quantification) from cutaneous neurofibromas and matched samples from NF1 patients in the CTF Biobank pilot project.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 44,\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\",\n      \"Molecular Characterization\",\n      \"BAM\",\n      \"FASTQ\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 33,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Transcriptomics\"\n    ],\n    \"title\": \"RNA-Seq\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"CTF Biobank cNF Project Team\",\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ format) from cutaneous neurofibromas and matched samples from 11 NF1 patients in the CTF Biobank pilot project. These appear to be merged files per sample.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 33,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Raw data\"\n    ],\n    \"title\": \"Raw cNF RNAseq Files\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"CTF Biobank cNF Project Team\",\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Raw, unmerged RNA sequencing data (FASTQ format) from cutaneous neurofibromas and matched samples from 11 NF1 patients in the CTF Biobank pilot project. Files likely represent individual sequencing lanes or runs before merging.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"FASTQ\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 33,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Raw data\"\n    ],\n    \"title\": \"Raw cNF RNAseq Files (unmerged)\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Sara Gosline\",\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"SNP array genotyping data from cutaneous neurofibromas and matched samples from 11 NF1 patients in the CTF Biobank pilot project. Used for genomic variant analysis.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"keywords\": [\n      \"SNP\",\n      \"SNP Array\",\n      \"Genotyping\",\n      \"Genomic Variants\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"SNP array\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 48,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Genomics\",\n      \"Genotyping\",\n      \"Single Nucleotide Polymorphisms\"\n    ],\n    \"title\": \"SNP Array Data\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Sara Gosline\",\n    \"dataType\": [\n      \"dataIndex\",\n      \"clinical\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Metadata including sample manifests, experimental protocols (WGS, RNA-seq, Proteomics, SNP array), clinical report forms (CRF), and patient data for the CTF Biobank cNF pilot project.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"Metadata\",\n      \"Sample Information\",\n      \"Clinical Data\",\n      \"Protocols\",\n      \"Manifest\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"questionnaire\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Metadata\",\n      \"Clinical Data\",\n      \"Protocols\"\n    ],\n    \"title\": \"Sample Information and Metadata\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"Thomas Yu, Sara Gosline\",\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"Whole Genome Sequencing (WGS) data, including variant calls (VCF, MAF) and alignments (BAM), from cutaneous neurofibromas and matched samples from NF1 patients in the CTF Biobank pilot project.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 15,\n    \"keywords\": [\n      \"Whole Genome Sequencing\",\n      \"WGS\",\n      \"Genomic Variants\",\n      \"VCF\",\n      \"MAF\",\n      \"BAM\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 62,\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"Genomics\",\n      \"Whole Genome Sequencing\",\n      \"Sequence Variation\"\n    ],\n    \"title\": \"Whole Genome Sequencing Data\"\n  },\n  {\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and adherence to data use terms. Refer to project documentation (syn4984604) for details.\",\n    \"contributor\": [\n      \"Children's Tumor Foundation\"\n    ],\n    \"creator\": \"CTF Biobank cNF Project Team\",\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\",\n      \"Health or Medical or Biomedical Research\"\n    ],\n    \"description\": \"RNA sequencing quantification results generated using Salmon for the cutaneous neurofibroma (cNF) samples from the CTF Biobank pilot project. Includes transcript and gene-level quantification.\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Quantification\",\n      \"Salmon\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"Cutaneous Neurofibroma\",\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"CTF Biobank\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn4984604\",\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Cutaneous Neurofibroma\",\n      \"RNA Sequencing\",\n      \"Gene Expression\",\n      \"Transcriptomics\"\n    ],\n    \"title\": \"cNF RNA-seq Quantification Files (Salmon)\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6790,
    "candidatesTokenCount": 4443,
    "totalTokenCount": 11233,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6790
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn6633069",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Copy Number Variation from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma CNV (WES)\",\n    \"description\": \"Copy number variation data derived from whole exome sequencing (WES) of tumor and normal samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Copy Number Variation\",\n      \"CNV\",\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Genomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Copy number variations\",\n      \"Exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Copy Number Variation Data from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma CNV (WES) Set 2\",\n    \"description\": \"Copy number variation data derived from whole exome sequencing (WES) of tumor and normal samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 59,\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Copy Number Variation\",\n      \"CNV\",\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Genomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Copy number variations\",\n      \"Exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Gene Expression Data from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma Gene Expression (RNA-Seq)\",\n    \"description\": \"Gene expression counts derived from RNA sequencing (RNA-Seq) of tumor samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 29,\n    \"specimenCount\": 32,\n    \"dataType\": [\n      \"geneExpression\",\n      \"raw counts\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"RNA-Seq\",\n      \"Transcriptomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Gene expression\",\n      \"RNA-Seq\",\n      \"Transcriptomes\"\n    ]\n  },\n  {\n    \"title\": \"Methylation Data from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma Methylation Array\",\n    \"description\": \"DNA methylation beta values derived from methylation arrays of tumor samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 31,\n    \"specimenCount\": 31,\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"measurementTechnique\": \"methylation array\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Methylation\",\n      \"DNA Methylation\",\n      \"Methylation Array\",\n      \"Epigenomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"DNA methylation\",\n      \"Microarray analysis\",\n      \"Epigenomics\"\n    ]\n  },\n  {\n    \"title\": \"Somatic Nucleotide Variation Data from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma SNV/Indel (WES)\",\n    \"description\": \"Somatic single nucleotide variations (SNVs) and small insertions/deletions (indels) derived from whole exome sequencing (WES) of tumor and normal samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 56,\n    \"specimenCount\": 102,\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Somatic Mutation\",\n      \"SNV\",\n      \"Indel\",\n      \"Nucleotide Variation\",\n      \"Whole Exome Sequencing\",\n      \"WES\",\n      \"Genomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Somatic mutation\",\n      \"Exome sequencing\",\n      \"Single nucleotide polymorphisms\",\n      \"Insertions (Genetics)\",\n      \"Deletions (Genetics)\"\n    ]\n  },\n  {\n    \"title\": \"Whole Genome Sequencing Variant Data from the Columbia University NF1 Glioma Project\",\n    \"alternateName\": \"Columbia NF1 Glioma WGS Variants\",\n    \"description\": \"Germline and somatic single nucleotide polymorphisms (SNPs) and small insertions/deletions (indels) identified via whole genome sequencing (WGS) of tumor and normal samples from individuals with Neurofibromatosis type 1 (NF1) associated low-grade and high-grade gliomas. Part of the Columbia University NF1 Glioma Project.\",\n    \"creator\": \"Antonio Iavarone\",\n    \"contributor\": [\n      \"Antonio Iavarone\",\n      \"Fulvio D'Angelo\",\n      \"Columbia University\"\n    ],\n    \"studyId\": \"syn6633069\",\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 11,\n    \"specimenCount\": 22,\n    \"dataType\": [\n      \"GermlineVariants\",\n      \"SomaticVariants\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"keywords\": [\n      \"Neurofibromatosis Type 1\",\n      \"NF1\",\n      \"Glioma\",\n      \"Low-Grade Glioma\",\n      \"High-Grade Glioma\",\n      \"Somatic Mutation\",\n      \"Germline Mutation\",\n      \"SNV\",\n      \"SNP\",\n      \"Indel\",\n      \"Whole Genome Sequencing\",\n      \"WGS\",\n      \"Genomics\"\n    ],\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Somatic mutation\",\n      \"Germ-line mutation\",\n      \"Genome-wide association studies\",\n      \"Single nucleotide polymorphisms\",\n      \"Insertions (Genetics)\",\n      \"Deletions (Genetics)\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5667,
    "candidatesTokenCount": 2981,
    "totalTokenCount": 8648,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5667
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn26347297",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Flow Cytometry Data for MPNST Inhibitor Study\",\n    \"creator\": \"Lindy Zhang\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Flow Cytometry\",\n      \"FACS\",\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Neurofibromatosis Type 1\",\n      \"Tumor Microenvironment\",\n      \"Immune Cells\",\n      \"MEK inhibitor\",\n      \"SHP2 inhibitor\",\n      \"CDK inhibitor\",\n      \"Drug Combination\",\n      \"RAS Pathway\",\n      \"Targeted Therapy\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"cellularPhysiology\",\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn26347297\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Flow cytometry data assessing the effects of RAS pathway inhibitors (MEK, SHP2, CDK) on tumor cells and the immune microenvironment in human Malignant Peripheral Nerve Sheath Tumors (MPNST). Data presented in XLSX format.\",\n    \"contributor\": [\n      \"Lindy Zhang\",\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\",\n      \"Johns Hopkins University\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"flow cytometry\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Immunohistochemistry Data for MPNST Inhibitor Study\",\n    \"creator\": \"Lindy Zhang\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Neurofibromatosis Type 1\",\n      \"Tumor Microenvironment\",\n      \"Immune Cells\",\n      \"MEK inhibitor\",\n      \"SHP2 inhibitor\",\n      \"CDK inhibitor\",\n      \"Drug Combination\",\n      \"RAS Pathway\",\n      \"Targeted Therapy\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"proteomics\",\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn26347297\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Immunohistochemistry data evaluating the impact of RAS pathway inhibitors (MEK, SHP2, CDK) on tumor cells and the immune microenvironment in human Malignant Peripheral Nerve Sheath Tumors (MPNST). Data presented in XLSX format.\",\n    \"contributor\": [\n      \"Lindy Zhang\",\n      \"Christine Pratilas\",\n      \"Nicolas Llosa\",\n      \"Johns Hopkins University\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"immunohistochemistry\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 274,
            "endIndex": 413,
            "uri": "https://www.hopkinsmedicine.org/kimmel_cancer_center/education_training/fellowships/pediatric_hematology_oncology/research_in_fellowship.html",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 4793,
    "candidatesTokenCount": 815,
    "totalTokenCount": 5608,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 4793
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn11817821",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Experiment 008 Analyzed Drug Screen and Imaging Data\",\n    \"creator\": \"Jeffrey Field\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"high throughput screening\",\n      \"drug sensitivity\",\n      \"cancer cell lines\",\n      \"rare cancers\",\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"drug screen\",\n      \"cell viability\",\n      \"immunofluorescence\",\n      \"analyzed data\",\n      \"Experiment 008\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"image\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Analyzed data from high-throughput drug screening (Experiment 008) on MPNST cell lines, including cell viability and immunofluorescence imaging results. Part of a research/education course initiative.\",\n    \"contributor\": [\n      \"yang yang\",\n      \"David Schultz\",\n      \"UPenn High Throughput Screening Core\",\n      \"Upenn/Merck High Throughput Experimentation Laboratory\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 2018,\n    \"subject\": [\n      \"High-throughput screening assays\",\n      \"Drug screening\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Neurofibromatosis 1\",\n      \"Cell viability\",\n      \"Immunofluorescence\"\n    ]\n  },\n  {\n    \"title\": \"Raw High-Throughput Drug Screen Data and Logs\",\n    \"creator\": \"Jeffrey Field\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"high throughput screening\",\n      \"drug sensitivity\",\n      \"cancer cell lines\",\n      \"rare cancers\",\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Neurofibromatosis type 2\",\n      \"NF2\",\n      \"drug screen\",\n      \"raw data\",\n      \"logs\",\n      \"cell lines\",\n      \"Schwannoma\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw output data and log files from high-throughput drug screening assays performed on a panel of 27 cell lines, including MPNST and Schwannoma lines derived from individuals with NF1 or NF2.\",\n    \"contributor\": [\n      \"yang yang\",\n      \"David Schultz\",\n      \"UPenn High Throughput Screening Core\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 27,\n    \"measurementTechnique\": \"cell viability assay\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Schwannoma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 2016,\n    \"subject\": [\n      \"High-throughput screening assays\",\n      \"Drug screening\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Neurofibromatosis 1\",\n      \"Neurofibromatosis 2\",\n      \"Schwannoma\",\n      \"Cell line\"\n    ]\n  },\n  {\n    \"title\": \"Exome Sequencing Data for NF1/NF2 Tumor Samples\",\n    \"creator\": \"Jeffrey Field\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"high throughput screening\",\n      \"drug sensitivity\",\n      \"cancer cell lines\",\n      \"rare cancers\",\n      \"MPNST\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Neurofibromatosis type 2\",\n      \"NF2\",\n      \"Schwannoma\",\n      \"exome sequencing\",\n      \"WES\",\n      \"genomic variants\",\n      \"tumor\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11817821\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Whole exome sequencing data (variants) generated from 13 individuals with Neurofibromatosis type 1 or type 2, including MPNST and Schwannoma tumor samples.\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 13,\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Schwannoma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 2016,\n    \"subject\": [\n      \"Whole exome sequencing\",\n      \"Genomic variants\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Neurofibromatosis 1\",\n      \"Neurofibromatosis 2\",\n      \"Schwannoma\",\n      \"Tumor genetics\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5748,
    "candidatesTokenCount": 1376,
    "totalTokenCount": 7124,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5748
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn4939876",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Drug Combination Screen Validation Data (Rapamycin/Ganetespib, Selumetinib/Panobinostat) in NF1 Cell Lines\",\n    \"alternateName\": \"NTAP Drug Combination Validation Clapp\",\n    \"description\": \"Validation data for two prioritized drug combinations (Rapamycin/Ganetespib, Selumetinib/Panobinostat) tested in murine and human NF1-deficient cell lines using viability and apoptosis assays (MTT, Caspase-Glo, CellTiter-Glo).\",\n    \"creator\": \"D. Wade Clapp\",\n    \"contributor\": [\n      \"D. Wade Clapp\",\n      \"Heather Daniel\",\n      \"Xindi Guo\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug screen\",\n      \"combination therapy\",\n      \"Neurofibromatosis 1\",\n      \"Plexiform Neurofibroma\",\n      \"cell lines\",\n      \"in vitro\",\n      \"viability assay\",\n      \"apoptosis assay\",\n      \"Rapamycin\",\n      \"Ganetespib\",\n      \"Selumetinib\",\n      \"Panobinostat\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"studyId\": \"syn4939876\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Plexiform neurofibromas\",\n      \"Drug screening\",\n      \"Cell lines\",\n      \"Antineoplastic combined chemotherapy protocols\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5100,
    "candidatesTokenCount": 477,
    "totalTokenCount": 5577,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5100
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn22267330",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Cell Viability Celigo Assays for MPNST Study\",\n    \"creator\": \"Laurel Black\",\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"MPNST Cell Viability and Drug Screen Data\",\n    \"conditionsOfAccess\": \"Requires Synapse account registration.\",\n    \"contributor\": [\n      \"Laurel E. Black\",\n      \"Jordan F. Longo\",\n      \"John C. Anderson\",\n      \"Steven L. Carroll\",\n      \"James Moon\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\",\n      \"drugScreen\",\n      \"drugCombinationScreen\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Cell viability assays (including drug and combination screens) using Celigo imaging system on Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines to investigate ErbB3 and calcium signaling pathways. Data includes images, gene expression, and screening results.\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 1,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Cell Viability\",\n      \"Drug Screen\",\n      \"Combination Screen\",\n      \"ErbB3\",\n      \"Calcium Signaling\",\n      \"Celigo\",\n      \"Imaging\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"subject\": [\n      \"Neurofibromatoses\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Calcium Signaling\",\n      \"Receptor Tyrosine Kinases\",\n      \"Drug Screening\",\n      \"Cell Proliferation\",\n      \"Cell Viability Assays\"\n    ]\n  },\n  {\n    \"title\": \"Immunocytochemistry Imaging Data for MPNST Study\",\n    \"creator\": \"Laurel Black\",\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"MPNST Immunocytochemistry Images\",\n    \"conditionsOfAccess\": \"Requires Synapse account registration.\",\n    \"contributor\": [\n      \"Laurel E. Black\",\n      \"Jordan F. Longo\",\n      \"John C. Anderson\",\n      \"Steven L. Carroll\",\n      \"James Moon\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Immunocytochemistry imaging data from Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines, related to the study of ErbB3 and calcium signaling pathways.\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 1,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Immunocytochemistry\",\n      \"Imaging\",\n      \"ErbB3\",\n      \"Microscopy\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"immunocytochemistry\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"subject\": [\n      \"Neurofibromatoses\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Immunocytochemistry\",\n      \"Microscopy\",\n      \"Receptor Tyrosine Kinases\"\n    ]\n  },\n  {\n    \"title\": \"Kinomic Analysis of MPNST Cells\",\n    \"creator\": \"Laurel Black\",\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"MPNST Kinomics Data\",\n    \"conditionsOfAccess\": \"Requires Synapse account registration.\",\n    \"contributor\": [\n      \"Laurel E. Black\",\n      \"Jordan F. Longo\",\n      \"John C. Anderson\",\n      \"Steven L. Carroll\",\n      \"James Moon\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Kinomic profiling data from Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines, generated using immunoassays (likely phospho-arrays) to investigate signaling pathways involving ErbB3 and calcium.\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 1,\n    \"keywords\": [\n      \"MPNST\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Kinomics\",\n      \"Immunoassay\",\n      \"Phospho-array\",\n      \"Signaling Pathways\",\n      \"ErbB3\",\n      \"Calcium Signaling\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"immunoassay\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn22267330\",\n    \"subject\": [\n      \"Neurofibromatoses\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"Kinases\",\n      \"Phosphorylation\",\n      \"Signal Transduction\",\n      \"Immunoassay\",\n      \"Calcium Signaling\",\n      \"Receptor Tyrosine Kinases\"\n    ]\n  },\n  {\n    \"title\": \"Microarray Gene Expression Data from NRG1β Stimulated Rat Schwann Cells\",\n    \"creator\": \"Laurel Black\",\n    \"accessType\": \"Controlled Access\",\n    \"alternateName\": \"Rat Schwann Cell NRG1β Stimulation Microarray\",\n    \"conditionsOfAccess\": \"Requires Synapse account registration.\",\n    \"contributor\": [\n      \"Laurel E. Black\",\n      \"Jordan F. Longo\",\n      \"John C. Anderson\",\n      \"Steven L. Carroll\",\n      \"James Moon\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Microarray gene expression data from Rattus norvegicus (rat) Schwann cells stimulated with NRG1β (an ErbB3 ligand), relevant to understanding signaling pathways implicated in Malignant Peripheral Nerve Sheath Tumor (MPNST).\",\n    \"diseaseFocus\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"individualCount\": 1,\n    \"keywords\": [\n      \"Schwann Cells\",\n      \"NRG1\",\n      \"ErbB3\",\n      \"Gene Expression\",\n      \"Microarray\",\n      \"Rattus norvegicus\"\n    ],\n    \"license\": \"UNKNOWN\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"array\",\n    \"species\": [\n      \"Rattus norvegicus\"\n    ],\n    \"specimenCount\": 1,\n    \"studyId\": \"syn22267330\",\n    \"subject\": [\n      \"Schwann Cells\",\n      \"Neuregulins\",\n      \"Gene Expression Profiling\",\n      \"Microarray Analysis\",\n      \"Rats\",\n      \"Neurofibromatoses\",\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5880,
    "candidatesTokenCount": 1860,
    "totalTokenCount": 7740,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5880
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn31619419",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Analysis Data for Cutaneous Neurofibroma Optical Imaging\",\n    \"creator\": \"Thomas E. Milner\",\n    \"contributor\": [\n      \"Wangcun Jia\",\n      \"Junsoo Lee\",\n      \"Christina Parry\",\n      \"University of California, Irvine\"\n    ],\n    \"description\": \"Contains analysis results, including marked images and concentration maps, derived from spatial frequency domain imaging (SFDI) and optical coherence tomography (OCT) of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients.\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"Spatial Frequency Domain Imaging\",\n      \"SFDI\",\n      \"Optical Coherence Tomography\",\n      \"OCT\",\n      \"Image Analysis\",\n      \"Biomarker\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"AggregatedData\"\n    ],\n    \"measurementTechnique\": \"spatial frequency domain imaging\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Cutaneous neurofibromas\",\n      \"Biomedical Imaging\",\n      \"Optical Imaging\",\n      \"Image Analysis\"\n    ]\n  },\n  {\n    \"title\": \"Histology Images of Cutaneous Neurofibroma and Uninvolved Skin\",\n    \"creator\": \"Thomas E. Milner\",\n    \"contributor\": [\n      \"Wangcun Jia\",\n      \"University of California, Irvine\"\n    ],\n    \"description\": \"Brightfield microscopy images comparing histology of visible cutaneous neurofibromas (cNF), suspected invisible cNF, and uninvolved skin from Neurofibromatosis type 1 patients, used for validating optical imaging findings.\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"Histology\",\n      \"Microscopy\",\n      \"Validation\",\n      \"Skin Biopsy\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"measurementTechnique\": \"brightfield microscopy\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Cutaneous neurofibromas\",\n      \"Histology\",\n      \"Microscopy\",\n      \"Biopsy\"\n    ]\n  },\n  {\n    \"title\": \"Optical Coherence Tomography (OCT) Images of Cutaneous Neurofibromas\",\n    \"creator\": \"Thomas E. Milner\",\n    \"contributor\": [\n      \"Junsoo Lee\",\n      \"Christina Parry\",\n      \"University of California, Irvine\"\n    ],\n    \"description\": \"Raw and processed optical coherence tomography (OCT) images, including attenuation maps, of cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients.\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"Optical Coherence Tomography\",\n      \"OCT\",\n      \"Biomedical Imaging\",\n      \"Skin Imaging\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"measurementTechnique\": \"optical coherence tomography\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Cutaneous neurofibromas\",\n      \"Optical coherence tomography\",\n      \"Biomedical Imaging\"\n    ]\n  },\n  {\n    \"title\": \"Clinical Photographs of Skin Areas with Cutaneous Neurofibromas\",\n    \"creator\": \"Thomas E. Milner\",\n    \"contributor\": [\n      \"Wangcun Jia\",\n      \"University of California, Irvine\"\n    ],\n    \"description\": \"Photographs documenting the appearance of skin areas, including visible cutaneous neurofibromas (cNF), in Neurofibromatosis type 1 patients participating in the study.\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"Clinical Photography\",\n      \"Skin Lesions\",\n      \"Patient Documentation\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"measurementTechnique\": \"photograph\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Cutaneous neurofibromas\",\n      \"Photography, Medical\",\n      \"Skin Diseases\"\n    ]\n  },\n  {\n    \"title\": \"Spatial Frequency Domain Imaging (SFDI) Data for Cutaneous Neurofibromas\",\n    \"creator\": \"Thomas E. Milner\",\n    \"contributor\": [\n      \"Wangcun Jia\",\n      \"University of California, Irvine\"\n    ],\n    \"description\": \"Raw and calibrated spatial frequency domain imaging (SFDI) data, including associated metadata files, acquired from skin areas with cutaneous neurofibromas (cNF) in Neurofibromatosis type 1 patients.\",\n    \"keywords\": [\n      \"Neurofibromatosis 1\",\n      \"NF1\",\n      \"Cutaneous Neurofibroma\",\n      \"cNF\",\n      \"Spatial Frequency Domain Imaging\",\n      \"SFDI\",\n      \"Biomedical Imaging\",\n      \"Optical Properties\",\n      \"Skin Imaging\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"metadata\"\n    ],\n    \"measurementTechnique\": \"spatial frequency domain imaging\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\",\n      \"NIH-NCI\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"studyId\": \"syn31619419\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Cutaneous neurofibromas\",\n      \"Spatial frequency domain imaging\",\n      \"Biomedical Imaging\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5683,
    "candidatesTokenCount": 2064,
    "totalTokenCount": 7747,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5683
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn4939890",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Gene expression profiling of Schwann cells and macrophages in mouse nerves and neurofibromas\",\n    \"creator\": \"Jianqiang Wu\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"gene expression\",\n      \"microarray\",\n      \"Schwann cell\",\n      \"macrophage\",\n      \"mouse model\",\n      \"neurofibroma\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"inflammation\",\n      \"interactome\",\n      \"Affymetrix Mouse Gene 2.0 ST Array\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn4939890\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Gene expression data from microarray analysis (Affymetrix Mouse Gene 2.0 ST Array) of Schwann cells and macrophages isolated from mouse nerves and plexiform neurofibromas. Part of a study exploring the neurofibroma interactome and the role of inflammation in NF1 tumor progression.\",\n    \"alternateName\": \"Mouse NF1 Gene Expression - SCs and Macrophages\",\n    \"contributor\": [\n      \"Kwangmn Choi\",\n      \"Kakajan Komurov\",\n      \"Nancy Ratner\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 1488326400000,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"RNA array\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Gene expression\",\n      \"Macrophages\",\n      \"Schwann cells\",\n      \"Mice--Research\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5591,
    "candidatesTokenCount": 494,
    "totalTokenCount": 6085,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5591
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn7217928",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Drug screen data from 3D Plexiform Neurofibroma Model System\",\n    \"alternateName\": \"NTAP 3D PN Drug Screen Data\",\n    \"creator\": \"Ray Mattingly\",\n    \"contributor\": [\n      \"Anh Nguyet Vu\",\n      \"Wayne State University\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug screen\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"3D model\",\n      \"preclinical\",\n      \"cell culture\",\n      \"imaging\",\n      \"co-culture\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"image\"\n    ],\n    \"measurementTechnique\": \"high content screen\",\n    \"studyId\": \"syn7217928\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Drug screen data generated using 3D co-culture models of NF1 plexiform neurofibromas (PNs) to test potential drug candidates. Includes imaging data and quantified results from assays like cell proliferation and collagen degradation.\"\n  },\n  {\n    \"title\": \"Drug screens with 3D Plexiform Neurofibroma Model System\",\n    \"alternateName\": \"NTAP 3D PN Model Drug Screens\",\n    \"creator\": \"Ray Mattingly\",\n    \"contributor\": [\n      \"Anh Nguyet Vu\",\n      \"Wayne State University\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"drug screen\",\n      \"plexiform neurofibroma\",\n      \"NF1\",\n      \"3D model\",\n      \"preclinical\",\n      \"cell culture\",\n      \"imaging\",\n      \"co-culture\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"image\"\n    ],\n    \"measurementTechnique\": \"high content screen\",\n    \"studyId\": \"syn7217928\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Plexiform Neurofibroma\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Drug screening results from experiments utilizing 3D co-culture models of NF1 plexiform neurofibromas (PNs). Data includes imaging and quantified results for assessing drug efficacy in a more representative preclinical system.\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5825,
    "candidatesTokenCount": 638,
    "totalTokenCount": 6463,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5825
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn61696875",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Mayo Clinic Cohort REDCap Database of De-identified Phenotype and Genotype Information\",\n    \"creator\": \"Mayowa Osundiji\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Mayo Clinic\",\n      \"REDCap\",\n      \"EHR\",\n      \"electronic health record\",\n      \"phenotype\",\n      \"genotype\",\n      \"clinical data\",\n      \"registry\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"aggregated data\"\n    ],\n    \"dataType\": [\n      \"clinical\",\n      \"AggregatedData\"\n    ],\n    \"studyId\": \"syn61696875\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"De-identified clinical phenotype and genotype data extracted from electronic health records (EHR) at Mayo Clinic Rochester for Neurofibromatosis type 1 patients. Data are aggregated and stored in a REDCap database format as part of an effort to supplement the Children's Tumor Foundation (CTF) Neurofibromatosis Registry.\",\n    \"alternateName\": \"Mayo Clinic NF1 EHR Data\",\n    \"conditionsOfAccess\": \"Access requires adherence to data use agreement.\",\n    \"contributor\": [\n      \"Mayo Clinic Arizona\",\n      \"Mayo Clinic Rochester\"\n    ],\n    \"countryOfOrigin\": [\n      \"United States of America\"\n    ],\n    \"dataUseModifiers\": [\n      \"Health or Medical or Biomedical Research\",\n      \"Disease Specific Research\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor\"\n    ],\n    \"measurementTechnique\": \"genotyping\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis Type 1\",\n      \"Electronic health records\",\n      \"Phenotype\",\n      \"Genotype\",\n      \"Medical registries\",\n      \"Malignant peripheral nerve sheath tumors\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 217,
            "endIndex": 357,
            "uri": "https://staging.synapse.org/Profile:3423450",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5051,
    "candidatesTokenCount": 540,
    "totalTokenCount": 5591,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5051
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn2343195",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Synodos NF2 Jumping Library Sequencing Data (2017 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Jumping Library\",\n      \"Structural Variants\",\n      \"Genomic Variants\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"2017\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Jumping Library Seq 2017\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed jumping library sequencing data (BAM files) generated from 11 human and mouse cell line models of NF2-related meningioma and schwannoma as part of the Synodos NF2 2017 data release. Facilitates detection of chromosomal abnormalities.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"jumping library\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 12,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Genomics\",\n      \"Structural Variants\",\n      \"Cell Lines\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Kinomics Data (2017 Release)\",\n    \"creator\": \"Abhishek Pratap\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Kinomics\",\n      \"Proteomics\",\n      \"MIB/MS\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"Drug Treatment\",\n      \"2017\"\n    ],\n    \"dataType\": [\n      \"kinomics\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Kinome Data 2017\",\n    \"contributor\": [\n      \"Abhishek Pratap\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed kinomics data (MIB/MS) from human and mouse cell line models of NF2 meningioma and schwannoma, including response to small molecule treatments. Part of the Synodos NF2 2017 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 11,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"MIB/MS\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 9,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Proteomics\",\n      \"Kinases\",\n      \"Cell Lines\",\n      \"Drug Effects\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 In Vivo Animal Study Data (2019 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Animal Model\",\n      \"In Vivo\",\n      \"Bioluminescence\",\n      \"Tumor Volume\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Mus musculus\",\n      \"Drug Treatment\",\n      \"2019\"\n    ],\n    \"dataType\": [\n      \"Volume\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Animal Studies 2019\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"In vivo bioluminescence imaging data measuring tumor volume in mouse models of NF2 meningioma treated with various drug combinations. Part of the Synodos NF2 2019 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"measurementTechnique\": \"in vivo bioluminescence\",\n    \"species\": [\n      \"Mus musculus\",\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 2,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Animal Models\",\n      \"Drug Therapy\",\n      \"Tumor Volume\",\n      \"Bioluminescence Imaging\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 High-Throughput Drug Screen Data (2019 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Drug Screen\",\n      \"High-Throughput Screening\",\n      \"Cell Viability\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"Cell Lines\",\n      \"2019\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 HTS Data 2019\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"High-throughput drug screening data (cell viability assays) from 7 human and mouse cell line models of NF2 meningioma and schwannoma. Part of the Synodos NF2 2019 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 7,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 15,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Drug Screening\",\n      \"High-Throughput Screening Assays\",\n      \"Cell Viability\",\n      \"Cell Lines\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Proteomics and Kinomics Data (2019 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Kinomics\",\n      \"Proteomics\",\n      \"Immunoassay\",\n      \"ELISA\",\n      \"MIB/MS\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"Drug Treatment\",\n      \"2019\"\n    ],\n    \"dataType\": [\n      \"kinomics\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Proteomics/Kinome Data 2019\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Proteomics and kinomics data (MIB/MS, sandwich ELISA) from human and mouse cell line models of NF2 meningioma and schwannoma, including effects of drug treatments. Part of the Synodos NF2 2019 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 3,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"MIB/MS\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 2,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Proteomics\",\n      \"Kinases\",\n      \"Immunoassay\",\n      \"Cell Lines\",\n      \"Drug Effects\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 RNA Sequencing Data (2019 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"Cell Lines\",\n      \"2019\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 RNA-Seq Data 2019\",\n    \"contributor\": [\n      \"Serkan Erdin\",\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Raw and processed RNA sequencing data (FASTQ, BAM, counts) from human and mouse cell line models of NF2 meningioma and schwannoma. Part of the Synodos NF2 2019 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 109,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Transcriptome\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Cell Lines\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Raw Blot Images (2021)\",\n    \"creator\": \"Abbi Smith\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Blot Images\",\n      \"Raw Data\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Synodos\",\n      \"CTF\",\n      \"2021\",\n      \"Western Blot\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Raw Blot Images 2021\",\n    \"contributor\": [\n      \"Abbi Smith\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Raw blot images (likely Western blots or similar) generated as part of the Synodos NF2 project. Details regarding samples and conditions require examination of the file(s).\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"measurementTechnique\": \"western blot\",\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Western Blotting\",\n      \"Molecular Biology\",\n      \"Image Data\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Gene Expression Quantification from RNA-seq\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Quantification\",\n      \"Transcriptomics\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 RNA-Seq Gene Quantification\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed gene expression quantification data (likely transcript counts or TPM/FPKM) derived from RNA sequencing of NF2 schwannoma samples from the Synodos NF2 project.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 2,\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Schwannoma\",\n      \"Transcriptome\",\n      \"Gene Expression\",\n      \"RNA Sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 RNASeq Reprocessing by NF-OSI\",\n    \"creator\": \"Sara Gosline\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Quantification\",\n      \"Transcriptomics\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"NF-OSI\",\n      \"Reprocessed Data\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF-OSI Reprocessed NF2 RNA-Seq\",\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Reprocessed RNA sequencing gene expression quantification data from NF2 human meningioma samples, originally generated by the Synodos NF2 project. Processed by the NF-OSI team.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 75,\n    \"manifestation\": [\n      \"Meningioma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"series\": \"NF-OSI Processed Data\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 84,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Transcriptome\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Data Reprocessing\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Processed Drug Screen Data (2017 Release)\",\n    \"creator\": \"Abhishek Pratap\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Drug Screen\",\n      \"Processed Data\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Cell Lines\",\n      \"2017\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Drug Screen Processed 2017\",\n    \"contributor\": [\n      \"Abhishek Pratap\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed results from drug screens conducted on NF2 models (likely cell lines) as part of the Synodos NF2 2017 data release. Contains combined raw and processed data files.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"drug screen\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Drug Screening\",\n      \"Cell Lines\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Processed RNA-seq Data (2017 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Gene Expression\",\n      \"Processed Data\",\n      \"Differential Expression\",\n      \"Counts\",\n      \"Transcriptomics\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"2017\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Processed RNA-Seq 2017\",\n    \"contributor\": [\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Processed RNA sequencing data from the Synodos NF2 2017 release, including raw counts and differential gene expression results for meningioma and schwannoma models.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Transcriptome\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Differential Gene Expression\"\n    ]\n  },\n  {\n    \"title\": \"Synodos NF2 Raw RNA Sequencing Data (2017 Release)\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-Seq\",\n      \"Raw Data\",\n      \"Gene Expression\",\n      \"Transcriptomics\",\n      \"FASTQ\",\n      \"BAM\",\n      \"NF2\",\n      \"Neurofibromatosis type 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Synodos\",\n      \"CTF\",\n      \"Homo sapiens\",\n      \"Mus musculus\",\n      \"Cell Lines\",\n      \"2017\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn2343195\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 2\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"alternateName\": \"NF2 Raw RNA-Seq Data 2017\",\n    \"contributor\": [\n      \"Steven Angus\",\n      \"Robert Allaway\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ, BAM) from human and mouse cell line models of NF2 meningioma and schwannoma. Part of the Synodos NF2 2017 data release.\",\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"individualCount\": 47,\n    \"manifestation\": [\n      \"Meningioma\",\n      \"Schwannoma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\",\n      \"Mus musculus\"\n    ],\n    \"specimenCount\": 205,\n    \"subject\": [\n      \"Neurofibromatosis 2\",\n      \"Meningioma\",\n      \"Schwannoma\",\n      \"Transcriptome\",\n      \"Gene Expression\",\n      \"RNA Sequencing\",\n      \"Raw Data\",\n      \"Cell Lines\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7693,
    "candidatesTokenCount": 5565,
    "totalTokenCount": 13258,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7693
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn11374349",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"12 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"immunohistochemistry\",\n      \"quantitative PCR\",\n      \"flow cytometry\",\n      \"gene expression\",\n      \"imaging\",\n      \"cell cycle\",\n      \"karyotyping\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 12 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes cell cycle, qRT-PCR, karyotyping, and staining data.\",\n    \"measurementTechnique\": \"flow cytometry\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"18 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"western blot\",\n      \"flow cytometry\",\n      \"quantitative PCR\",\n      \"immunohistochemistry\",\n      \"immunofluorescence\",\n      \"imaging\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"image\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 18 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes western blot, Annexin V-PI staining, qRT-PCR, immunostaining, and FACS data.\",\n    \"measurementTechnique\": \"immunofluorescence\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"24 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"western blot\",\n      \"quantitative PCR\",\n      \"immunofluorescence\",\n      \"immunocytochemistry\",\n      \"gene expression\",\n      \"immunoassay\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"geneExpression\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 24 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes western blot, qRT-PCR, FACS analysis, and immunostaining data.\",\n    \"measurementTechnique\": \"quantitative PCR\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"30 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"immunocytochemistry\",\n      \"atomic force microscopy\",\n      \"immunofluorescence\",\n      \"RNA-seq\",\n      \"quantitative PCR\",\n      \"immunoassay\",\n      \"imaging\",\n      \"gene expression\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"immunoassay\",\n      \"image\",\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 30 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes FACS sorting, RNA-seq, MBP staining, and TEM data.\",\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 1,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"36 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"contributor\": [\n      \"NF Service\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"cell viability assay\",\n      \"quantitative PCR\",\n      \"atomic force microscopy\",\n      \"RNA-seq\",\n      \"immunofluorescence\",\n      \"cellular physiology\",\n      \"gene expression\",\n      \"imaging\",\n      \"immunoassay\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"cellularPhysiology\",\n      \"geneExpression\",\n      \"image\",\n      \"immunoassay\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 36 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes RNA-seq, cell cycle analysis, cell proliferation, qRT-PCR, and TEM data.\",\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 16,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"6 Month Deliverables - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"Sanger sequencing\",\n      \"genomic variants\",\n      \"donor vector\",\n      \"transfection\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Data generated after 6 months for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Includes donor vector construction, transfection, sequencing, and cell expansion data.\",\n    \"measurementTechnique\": \"Sanger sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Gene Expression Quantification from RNA-seq - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"NF Service\",\n    \"contributor\": [\n      \"Gabsang Lee\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"quantification\",\n      \"processed data\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Processed gene expression quantification data (Salmon quant.sf files) derived from RNA-seq experiments in the study modeling NF1 using human Schwann cells with tunable NF1 protein control.\",\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 16,\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  },\n  {\n    \"title\": \"Raw RNA-seq Data (fastq) - Modeling NF1 with Human Schwann Cells\",\n    \"creator\": \"Gabsang Lee\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Schwann cells\",\n      \"human embryonic stem cells\",\n      \"hESC\",\n      \"gene editing\",\n      \"SMASh tag\",\n      \"cutaneous neurofibroma\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"raw data\",\n      \"fastq\",\n      \"Homo sapiens\",\n      \"NTAP\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn11374349\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"NTAP\"\n    ],\n    \"description\": \"Raw RNA sequencing data (fastq files) generated for the study modeling NF1 using human Schwann cells with tunable NF1 protein control. Submitted for processing by NF-OSI.\",\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"manifestation\": [\n      \"Cutaneous Neurofibroma\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 6350,
    "candidatesTokenCount": 2952,
    "totalTokenCount": 9302,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 6350
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn5698493",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Synodos LGG Methylation Arrays\",\n    \"alternateName\": \"NF1 LGG Methylation Data\",\n    \"description\": \"Methylation array data (IDAT files) for 43 individuals with Neurofibromatosis type 1 associated low-grade gliomas, generated as part of the Synodos for NF1 - Low Grade Glioma project.\",\n    \"creator\": \"Synodos for NF1 - Low Grade Glioma\",\n    \"contributor\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and agreement to data use terms.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"methylation array\",\n      \"epigenomics\",\n      \"NF1\",\n      \"low-grade glioma\",\n      \"pilocytic astrocytoma\",\n      \"chromatin activity\",\n      \"IDAT\",\n      \"glioma\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\"\n    ],\n    \"measurementTechnique\": \"methylation array\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 43,\n    \"specimenCount\": 43,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"DNA Methylation\",\n      \"Astrocytoma\",\n      \"Epigenomics\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Synodos LGG RNAseq\",\n    \"alternateName\": \"NF1 LGG RNA Sequencing Data\",\n    \"description\": \"RNA sequencing data (fastq files) for 23 individuals with Neurofibromatosis type 1 associated low-grade gliomas from the Synodos for NF1 - Low Grade Glioma project.\",\n    \"creator\": \"Synodos for NF1 - Low Grade Glioma\",\n    \"contributor\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and agreement to data use terms.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"RNA-seq\",\n      \"gene expression\",\n      \"transcriptomics\",\n      \"NF1\",\n      \"low-grade glioma\",\n      \"pilocytic astrocytoma\",\n      \"fastq\",\n      \"glioma\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 23,\n    \"specimenCount\": 23,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Transcriptomes\",\n      \"Sequence Analysis, RNA\",\n      \"Astrocytoma\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  },\n  {\n    \"title\": \"Synodos LGG Whole Genome Sequencing (bam)\",\n    \"alternateName\": \"NF1 LGG WGS BAM Data\",\n    \"description\": \"Whole Genome Sequencing alignment data (BAM files) for 22 individuals (44 specimens including tumor/normal pairs) with Neurofibromatosis type 1 associated low-grade gliomas from the Synodos for NF1 - Low Grade Glioma project.\",\n    \"creator\": \"Synodos for NF1 - Low Grade Glioma\",\n    \"contributor\": [\n      \"Synodos for NF1 - Low Grade Glioma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"studyId\": \"syn5698493\",\n    \"accessType\": \"Controlled Access\",\n    \"conditionsOfAccess\": \"Access requires Synapse registration and agreement to data use terms.\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"whole genome sequencing\",\n      \"WGS\",\n      \"genomic variants\",\n      \"aligned reads\",\n      \"NF1\",\n      \"low-grade glioma\",\n      \"pilocytic astrocytoma\",\n      \"bam\",\n      \"glioma\",\n      \"Neurofibromatosis type 1\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\",\n      \"genomicVariants\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"manifestation\": [\n      \"Low-Grade Glioma\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 22,\n    \"specimenCount\": 44,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Glioma\",\n      \"Genome, Human\",\n      \"Sequence Analysis, DNA\",\n      \"Astrocytoma\",\n      \"Genomics\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5609,
    "candidatesTokenCount": 1423,
    "totalTokenCount": 7032,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5609
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn21984813",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Animal Tumor Growth Studies\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"in vivo\",\n      \"drug screen\",\n      \"tumor growth\",\n      \"preclinical model\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"In vivo tumor growth data from NF1-MPNST patient-derived xenograft (PDX) models treated with various drug combinations.\",\n    \"alternateName\": \"NF1-MPNST PDX In Vivo Drug Response\",\n    \"contributor\": [\n      \"Ana Calizo\",\n      \"Himanshi Bhatia\",\n      \"Daniel Schefer\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 9,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"in vivo tumor growth\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Drug screening\"\n    ]\n  },\n  {\n    \"title\": \"Batch 1 RNA-seq (Drug Treated Cell Lines)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"drug treatment\",\n      \"drug response\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"RNA sequencing data from Batch 1, likely derived from drug-treated cell lines related to NF1-MPNST preclinical models.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Gene expression\",\n      \"Drug effects\",\n      \"Transcriptomics\"\n    ]\n  },\n  {\n    \"title\": \"Cell Growth Data Annotation Files\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"cell growth\",\n      \"annotation\",\n      \"metadata\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Annotation files associated with cell growth experiments performed on NF1-MPNST preclinical models.\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Cell proliferation\",\n      \"Metadata\"\n    ]\n  },\n  {\n    \"title\": \"Drug Combination Incucyte Data\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"drug combination\",\n      \"Incucyte\",\n      \"cell viability\",\n      \"high throughput screen\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Incucyte live-cell analysis data assessing the effects of drug combinations on NF1-MPNST models, likely measuring cell proliferation or viability.\",\n    \"contributor\": [\n      \"Sara Gosline\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Drug screening\",\n      \"Cell survival\",\n      \"High-throughput screening assays\"\n    ]\n  },\n  {\n    \"title\": \"Batch 2 RNA-seq Data (Hirbe Lab)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"RNA-seq\",\n      \"gene expression\",\n      \"fastq\"\n    ],\n    \"dataType\": [\n      \"geneExpression\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Raw RNA sequencing data (FASTQ files) from Batch 2, generated from NF1-MPNST patient tumors and patient-derived xenograft (PDX) models.\",\n    \"alternateName\": \"NF1-MPNST PDX RNA-seq Batch 2\",\n    \"contributor\": [\n      \"Kuangying Yang\",\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"RNA-seq\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 16,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Gene expression\",\n      \"Transcriptomics\"\n    ]\n  },\n  {\n    \"title\": \"Incucyte Drug Response Data\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"drug screen\",\n      \"cell viability\",\n      \"Incucyte\",\n      \"drug response\"\n    ],\n    \"dataType\": [\n      \"drugScreen\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Quantitative drug response data measured using the Incucyte system for NF1-MPNST patient-derived xenograft (PDX) models treated with various drugs.\",\n    \"alternateName\": \"NF1-MPNST PDX Incucyte Drug Screen\",\n    \"contributor\": [\n      \"Ana Calizo\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 4,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"cell viability assay\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Drug screening\",\n      \"Cell survival\"\n    ]\n  },\n  {\n    \"title\": \"Whole Exome Sequencing Somatic Variants (MAF format, Johns Hopkins Samples)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"somatic mutations\",\n      \"genomic variants\",\n      \"MAF\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Somatic variant calls in MAF format derived from whole exome sequencing (WES) of Johns Hopkins NF1-MPNST patient and PDX samples.\",\n    \"alternateName\": \"JH NF1-MPNST WES Somatic Variants (MAF)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 6,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 6,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Somatic mutation\",\n      \"Whole exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Batch 2 Whole Exome Sequencing Raw Data (FASTQ)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"genomic variants\",\n      \"fastq\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ files) from Batch 2, including NF1 patient tumor, normal, and PDX samples encompassing MPNST and atypical neurofibroma.\",\n    \"alternateName\": \"NF1-MPNST WES Batch 2 Raw Reads (FASTQ)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 21,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Atypical neurofibroma\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Whole exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Batch 2 Whole Exome Sequencing Aligned Reads (BAM)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"genomic variants\",\n      \"BAM\",\n      \"aligned reads\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Aligned whole exome sequencing reads (BAM files) from Batch 2, corresponding to NF1 patient tumor, normal, and PDX samples (MPNST, Atypical Neurofibroma).\",\n    \"alternateName\": \"NF1-MPNST WES Batch 2 Aligned Reads (BAM)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 14,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Atypical neurofibroma\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Whole exome sequencing\",\n      \"Sequence alignment\"\n    ]\n  },\n  {\n    \"title\": \"Batch 2 Whole Genome Sequencing Raw Data (FASTQ)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WGS\",\n      \"whole genome sequencing\",\n      \"genomic variants\",\n      \"fastq\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Raw whole genome sequencing data (FASTQ files) from Batch 2, including NF1 patient tumor, normal, and PDX samples encompassing MPNST and atypical neurofibroma.\",\n    \"alternateName\": \"NF1-MPNST WGS Batch 2 Raw Reads (FASTQ)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 22,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Atypical neurofibroma\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Whole genome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Batch 2 Whole Genome Sequencing Aligned Reads (BAM)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WGS\",\n      \"whole genome sequencing\",\n      \"genomic variants\",\n      \"BAM\",\n      \"aligned reads\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Aligned whole genome sequencing reads (BAM/BAI files) from Batch 2, corresponding to NF1 patient tumor, normal, and PDX samples.\",\n    \"alternateName\": \"NF1-MPNST WGS Batch 2 Aligned Reads (BAM)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Atypical neurofibroma\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Whole genome sequencing\",\n      \"Sequence alignment\"\n    ]\n  },\n  {\n    \"title\": \"Batch 1 Whole Exome Sequencing Aligned Reads (BAM)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"genomic variants\",\n      \"BAM\",\n      \"aligned reads\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Aligned whole exome sequencing reads (BAM files) from Batch 1 (2020), corresponding to NF1 patient tumor, normal, and PDX samples.\",\n    \"alternateName\": \"NF1-MPNST WES Batch 1 Aligned Reads (BAM)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 27,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Whole exome sequencing\",\n      \"Sequence alignment\"\n    ]\n  },\n  {\n    \"title\": \"NF-OSI Processed Data (January 2023)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"NF-OSI\",\n      \"processed data\",\n      \"BAM\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Processed genomic data (BAM files) generated through the NF-OSI processing pipeline, timestamped January 2023.\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Sequence alignment\"\n    ],\n    \"yearProcessed\": 2023\n  },\n  {\n    \"title\": \"NF-OSI Processed Data (December 2022)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"NF-OSI\",\n      \"processed data\",\n      \"BAM\"\n    ],\n    \"dataType\": [\n      \"AlignedReads\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Processed genomic data (BAM files) generated through the NF-OSI processing pipeline, timestamped December 2022.\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"series\": \"NF-OSI Processed Data\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Sequence alignment\"\n    ],\n    \"yearProcessed\": 2022\n  },\n  {\n    \"title\": \"Proteomics and Phosphoproteomics Data\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"proteomics\",\n      \"phosphoproteomics\",\n      \"mass spectrometry\"\n    ],\n    \"dataType\": [\n      \"proteomics\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Global and phosphoproteomic datasets generated from NF1-MPNST preclinical models, likely using mass spectrometry.\",\n    \"contributor\": [\n      \"Sara Gosline\",\n      \"Camilo Posso\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"mass spectrometry\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Proteomics\",\n      \"Phosphoproteomics\",\n      \"Mass spectrometry\"\n    ]\n  },\n  {\n    \"title\": \"Sample Annotation File\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"annotation\",\n      \"metadata\",\n      \"sample information\"\n    ],\n    \"dataType\": [\n      \"characteristic\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Annotation file containing metadata for samples used in the NF1-MPNST preclinical modeling project, potentially linking samples across datasets.\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Metadata\"\n    ]\n  },\n  {\n    \"title\": \"Somatic Variant Calls from Whole Exome Sequencing (2020, MAF)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"somatic mutations\",\n      \"genomic variants\",\n      \"MAF\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Somatic variant calls (MAF format) derived from whole exome sequencing (WES) of NF1-MPNST PDX samples from the 2020 batch.\",\n    \"alternateName\": \"NF1-MPNST PDX WES 2020 Somatic Variants (MAF)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Somatic mutation\",\n      \"Whole exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Updated Somatic Variant Calls from Whole Exome Sequencing (MAF)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"somatic mutations\",\n      \"genomic variants\",\n      \"MAF\",\n      \"VCF review\"\n    ],\n    \"dataType\": [\n      \"SomaticVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Updated somatic variant calls (MAF format) derived from whole exome sequencing (WES) of NF1 patient tumor and PDX samples, including MPNST and atypical neurofibroma. May include results from VCF review.\",\n    \"alternateName\": \"NF1-MPNST Updated WES Somatic Variants (MAF)\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"individualCount\": 7,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\",\n      \"Atypical Neurofibroma\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"specimenCount\": 14,\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Atypical neurofibroma\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Somatic mutation\",\n      \"Whole exome sequencing\"\n    ]\n  },\n  {\n    \"title\": \"Copy Number Variation Analysis using CNVkit from WGS (MGI 2020)\",\n    \"creator\": \"Angela Hirbe, David Largaespada\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF1\",\n      \"MPNST\",\n      \"PDX\",\n      \"WGS\",\n      \"whole genome sequencing\",\n      \"copy number variation\",\n      \"CNV\",\n      \"CNVkit\"\n    ],\n    \"dataType\": [\n      \"CopyNumberVariants\"\n    ],\n    \"studyId\": \"syn21984813\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\",\n      \"NIH-NCI\"\n    ],\n    \"description\": \"Copy number variation (CNV) analysis results generated using CNVkit from whole genome sequencing (WGS) data (MGI Batch 2, associated with DT-2862930) of NF1-MPNST PDX samples.\",\n    \"alternateName\": \"NF1-MPNST PDX WGS CNVkit Results\",\n    \"contributor\": [\n      \"Yang Lyu\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Xenografts\",\n      \"Genomics\",\n      \"Copy number variation\",\n      \"Whole genome sequencing\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 9706,
    "candidatesTokenCount": 7515,
    "totalTokenCount": 17221,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 9706
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn5562324",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"CTF-UCF-Cenix Phenotypic Compound Drug Screen Data\",\n    \"alternateName\": \"CTF-UCF-Cenix Complete Compound Drug Screen\",\n    \"creator\": \"Dr. Cristina Fernandez-Valle\",\n    \"contributor\": [\n      \"Cenix Bioscience\",\n      \"Children's Tumor Foundation\",\n      \"Abhishek Pratap\"\n    ],\n    \"accessType\": \"Open Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"NF2\",\n      \"Schwann cell\",\n      \"drug screen\",\n      \"high content assay\",\n      \"phenotypic screen\",\n      \"EdU\",\n      \"Cenix\",\n      \"UCF\",\n      \"mouse model\",\n      \"cell line\",\n      \"drug combination screen\"\n    ],\n    \"dataType\": [\n      \"drugScreen\",\n      \"cellularPhysiology\"\n    ],\n    \"measurementTechnique\": \"high content screen\",\n    \"studyId\": \"syn5562324\",\n    \"diseaseFocus\": [\n      \"NF2-related schwannomatosis\"\n    ],\n    \"manifestation\": [\n      \"Schwannoma\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"description\": \"Results from a phenotypic drug screen evaluating 95 compounds on NF2-/- (MS01) and NF2 wild-type (MS11) mouse Schwann cells. High-content imaging assessed nuclear phenotypes, including EdU incorporation, after 48-hour treatment across an 8-point dose response.\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"subject\": [\n       \"Neurofibromatosis 2\",\n       \"Schwann cells\",\n       \"Drug screening\",\n       \"High-throughput screening assays\",\n       \"Phenotype\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\"\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 4879,
    "candidatesTokenCount": 478,
    "totalTokenCount": 5357,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 4879
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn22392179",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"MPNST Cell Line Methylation Arrays\",\n    \"creator\": \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"methylation array\",\n      \"epigenomics\",\n      \"Neurofibromatosis type 1\",\n      \"chromatin activity\",\n      \"idat\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw methylation array data (IDAT files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line Methylation Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"methylation array\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Epigenomics\",\n      \"DNA methylation\"\n    ]\n  },\n  {\n    \"title\": \"MPNST Cell Line SNP Arrays\",\n    \"creator\": \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"SNP array\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"txt\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw SNP array data (TXT files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line SNP Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"SNP array\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Genome-wide association studies\"\n    ]\n  },\n  {\n    \"title\": \"MPNST Cell Line Whole Exome Sequencing\",\n    \"creator\": \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"fastq\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line WES Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Exome sequencing\",\n      \"Sequence analysis, DNA\"\n    ]\n  },\n  {\n    \"title\": \"MPNST Cell Line Whole Genome Sequencing\",\n    \"creator\": \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"WGS\",\n      \"whole genome sequencing\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"fastq\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw whole genome sequencing data (FASTQ files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line WGS Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Sequence analysis, DNA\"\n    ]\n  },\n  {\n    \"title\": \"Methylation\",\n    \"creator\": \"Bernat Gel Moreno, Robert Allaway\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"methylation array\",\n      \"epigenomics\",\n      \"Neurofibromatosis type 1\",\n      \"chromatin activity\",\n      \"idat\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"chromatinActivity\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw methylation array data (IDAT files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line Methylation Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"methylation array\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Epigenomics\",\n      \"DNA methylation\"\n    ]\n  },\n  {\n    \"title\": \"SNP_array\",\n    \"creator\": \"Bernat Gel Moreno, Robert Allaway\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"SNP array\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"txt\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw SNP array data (TXT files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line SNP Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"SNP array\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Genome-wide association studies\"\n    ]\n  },\n  {\n    \"title\": \"WES\",\n    \"creator\": \"Bernat Gel Moreno, Robert Allaway\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"WES\",\n      \"whole exome sequencing\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"fastq\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw whole exome sequencing data (FASTQ files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line WES Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole exome sequencing\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Exome sequencing\",\n      \"Sequence analysis, DNA\"\n    ]\n  },\n  {\n    \"title\": \"WGS\",\n    \"creator\": \"Bernat Gel Moreno, Robert Allaway\",\n    \"accessType\": \"Public Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"MPNST\",\n      \"cell lines\",\n      \"WGS\",\n      \"whole genome sequencing\",\n      \"genomics\",\n      \"Neurofibromatosis type 1\",\n      \"genomic variants\",\n      \"fastq\",\n      \"IGTP\"\n    ],\n    \"dataType\": [\n      \"genomicVariants\"\n    ],\n    \"studyId\": \"syn22392179\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"Other\"\n    ],\n    \"description\": \"Raw whole genome sequencing data (FASTQ files) for 8 Malignant Peripheral Nerve Sheath Tumor (MPNST) cell lines. Part of a study assessing genomic integrity and potential misdiagnosis of common MPNST cell lines.\",\n    \"alternateName\": \"MPNST Cell Line WGS Data\",\n    \"contributor\": [\n      \"Hereditary Cancer Laboratory, Germans Trias i Pujol Research Institute (IGTP)\"\n    ],\n    \"species\": [\n      \"Homo sapiens\"\n    ],\n    \"individualCount\": 8,\n    \"specimenCount\": 8,\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"whole genome sequencing\",\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Cell lines\",\n      \"Genomics\",\n      \"Sequence analysis, DNA\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 7691,
    "candidatesTokenCount": 3601,
    "totalTokenCount": 11292,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 7691
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn11672851",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"Drug Target Explorer Database v4\",\n    \"creator\": \"Robert Allaway\",\n    \"accessType\": \"Open Access\",\n    \"license\": \"CC BY-SA\",\n    \"keywords\": [\n      \"drug discovery\",\n      \"polypharmacology\",\n      \"drug-target interactions\",\n      \"cheminformatics\",\n      \"pharmacology\",\n      \"target identification\",\n      \"structure-activity relationship\",\n      \"chemical biology\",\n      \"database\",\n      \"ChEMBL\",\n      \"DrugBank\",\n      \"DGIdb\",\n      \"ChemicalProbes.org\"\n    ],\n    \"dataType\": [\n      \"AggregatedData\",\n      \"dataIndex\"\n    ],\n    \"studyId\": \"syn11672851\",\n    \"diseaseFocus\": [\n      \"Multiple\"\n    ],\n    \"funder\": [\n      \"CTF\",\n      \"NTAP\"\n    ],\n    \"description\": \"Aggregated database (v4) of drug-target interactions from sources like ChEMBL, ChemicalProbes.org, DGIdb, and DrugBank. Contains compound names, synonyms, and curated associations, supporting the Drug Target Explorer application for cheminformatics analysis, target identification, and structure-activity relationship studies.\",\n    \"alternateName\": \"Polypharmacology Database v4\",\n    \"contributor\": [\n      \"ChEMBL\",\n      \"ChemicalProbes.org\",\n      \"DGIdb\",\n      \"DrugBank\",\n      \"Klaeger, et al, 2017\",\n      \"Sage Bionetworks\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"datePublished\": 2021,\n    \"includedInDataCatalog\": \"https://www.synapse.org/DataCatalog:0\",\n    \"subject\": [\n      \"Pharmacology\",\n      \"Cheminformatics\",\n      \"Drug Discovery\",\n      \"Databases\",\n      \"Molecular Targets\",\n      \"Structure-Activity Relationship\"\n    ],\n    \"visualizeDataOn\": [\n      \"https://shiny.synapse.org/users/rallaway/polypharmacology-db/\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0,
      "citationMetadata": {
        "citationSources": [
          {
            "startIndex": 5836,
            "endIndex": 5980,
            "uri": "https://www.ctf.org.au/page/112/schwannomatosis",
            "license": ""
          },
          {
            "startIndex": 5867,
            "endIndex": 6007,
            "uri": "https://github.com/monarch-initiative/mondo/issues/7663",
            "license": ""
          }
        ]
      }
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5905,
    "candidatesTokenCount": 514,
    "totalTokenCount": 6419,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5905
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
{ "custom_id": "syn37861830",
  "candidates": [
    {
      "content": {
        "parts": [
          {
            "text": "```json\n[\n  {\n    \"title\": \"IHC Quantification\",\n    \"creator\": \"Anh Nguyet Vu\",\n    \"accessType\": \"Controlled Access\",\n    \"license\": \"UNKNOWN\",\n    \"keywords\": [\n      \"Immunohistochemistry\",\n      \"IHC\",\n      \"Quantification\",\n      \"Neurofibromatosis type 1\",\n      \"NF1\",\n      \"Malignant Peripheral Nerve Sheath Tumor\",\n      \"MPNST\",\n      \"Mus musculus\",\n      \"Mouse model\",\n      \"Tumor microenvironment\",\n      \"STING pathway\",\n      \"raw counts\"\n    ],\n    \"dataType\": [\n      \"raw counts\"\n    ],\n    \"studyId\": \"syn37861830\",\n    \"diseaseFocus\": [\n      \"Neurofibromatosis type 1\"\n    ],\n    \"funder\": [\n      \"CTF\"\n    ],\n    \"description\": \"Raw quantification data derived from immunohistochemistry (IHC) staining of Malignant Peripheral Nerve Sheath Tumor (MPNST) tissues from Mus musculus models used in a study exploring the reprogramming of the tumor microenvironment for Neurofibromatosis type 1 (NF1) related malignancies.\",\n    \"alternateName\": \"MPNST IHC Quantification Data\",\n    \"contributor\": [\n      \"Bandarigoda Nipunika Somatilaka\",\n      \"University of Texas Southwestern Medical Center\"\n    ],\n    \"dataUseModifiers\": [\n      \"General Research Use\"\n    ],\n    \"manifestation\": [\n      \"Malignant Peripheral Nerve Sheath Tumor (MPNST)\"\n    ],\n    \"measurementTechnique\": \"immunohistochemistry\",\n    \"species\": [\n      \"Mus musculus\"\n    ],\n    \"subject\": [\n      \"Neurofibromatosis 1\",\n      \"Malignant peripheral nerve sheath tumors\",\n      \"Immunohistochemistry\",\n      \"Mice--Research\"\n    ]\n  }\n]\n```"
          }
        ],
        "role": "model"
      },
      "finishReason": "STOP",
      "index": 0
    }
  ],
  "usageMetadata": {
    "promptTokenCount": 5263,
    "candidatesTokenCount": 446,
    "totalTokenCount": 5709,
    "promptTokensDetails": [
      {
        "modality": "TEXT",
        "tokenCount": 5263
      }
    ]
  },
  "modelVersion": "gemini-2.5-pro-exp-03-25"
}
